Genomic Valley Biotech Limited (BOM:539206)

Genomic Valley Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	89	86	179	106	66	76
Market Cap Growth	-11.31%	-52.21%	68.80%	59.59%	-12.12%	4.87%
Enterprise Value	89	85	175	106	66	76
Last Close Price	29.25	28.00	58.59	34.71	21.75	24.75

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	440.83	282.23	50.26	698.35	10.25	-
PS Ratio	41.46	31.97	21.21	64.23	2.44	107.14
PB Ratio	2.27	2.18	4.59	2.99	1.88	2.63
P/TBV Ratio	2.27	2.18	4.59	2.99	1.88	2.63
P/FCF Ratio	-	-	1012.58	-	-	-
P/OCF Ratio	-	-	666.52	-	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	41.34	31.95	20.71	63.98	2.44	107.03
EV/EBITDA Ratio	261.99	195.34	39.77	694.00	7.55	-
EV/EBIT Ratio	296.90	213.42	40.00	747.67	7.62	-
EV/FCF Ratio	-	-	988.92	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Debt / Equity Ratio	-0.01	-0.01	-0.01	0.00	-0.01	0.00
Net Debt / EBITDA Ratio	-0.77	-0.60	-0.10	-0.40	-0.05	0.01
Net Debt / FCF Ratio	-	1.38	-2.56	0.30	0.05	0.00
Asset Turnover	-	0.06	0.19	0.04	0.66	0.01
Quick Ratio	-	7.31	4.93	3.21	2.53	0.08
Current Ratio	-	8.41	5.73	3.68	2.89	5.31
Return on Equity (ROE)	-	0.77%	9.57%	0.43%	20.24%	-0.25%
Return on Assets (ROA)	-	0.58%	6.29%	0.20%	13.25%	-5.00%
Return on Invested Capital (ROIC)	0.52%	0.78%	9.54%	0.40%	27.35%	-10.26%
Return on Capital Employed (ROCE)	-	1.00%	11.20%	0.40%	24.70%	-12.70%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	0.23%	0.35%	1.99%	0.14%	9.76%	-0.12%
FCF Yield	-0.21%	-0.22%	0.10%	-0.19%	-11.72%	-28.17%
Buyback Yield / Dilution	2.08%	0.43%	-0.24%	0.70%	1.79%	-1.91%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 5, 2026

Data Sources Report a data error